AMRZ vs APOG
Amrize Ltd. and Apogee Enterprises, Inc., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | AMRZ | APOG |
|---|---|---|
| Revenue | $11.8B | $1.4B |
| Net income | $1.2B | $54.1M |
| Gross margin | 25.7% | 22.7% |
| Net margin | 10.0% | 3.9% |
| Return on equity | 10.2% | 10.8% |
| Diluted EPS | $2.14 | $2.52 |
| Dividend / share | — | $1.05 |
| Payout ratio | — | 41.0% |
| Free cash flow | $1.4B | $95.2M |
| Equity | $13.3B | $511.8M |
| Net debt / equity | — | 0.38× |
| Current ratio | 1.64× | 1.65× |
| Revenue CAGR 5y | — | 2.7% |
| Profit CAGR 5y | — | 28.5% |
AMRZ bills 8.4× the revenue of APOG, and keeps more of each dollar of revenue as profit (10.0% against 3.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
3 years side by side
| Fiscal year | AMRZ | APOG |
|---|---|---|
| FY2025 | $11.8B | $1.4B |
| FY2024 | $11.7B | $1.4B |
| FY2023 | $11.7B | $1.4B |
Net income by year
Bottom line
| Fiscal year | AMRZ | APOG |
|---|---|---|
| FY2025 | $1.2B | $54.1M |
| FY2024 | $1.3B | $85.1M |
| FY2023 | $956.0M | $99.6M |